A simple blood test can identify people who are at risk for a heart attack, including thousands who don't have high cholesterol. The new test measures gamma-prime fibrinogen, a component of the ...

The current era of lipid lowering and consequent reduction of cardiovascular disease (CVD) has been notable for both remarkable progress and associated irony. Publication of the landmark trials ...

Congenital fibrinogen disorders encompass a heterogeneous group of inherited conditions affecting either the quantity or quality of fibrinogen, a critical glycoprotein in the coagulation cascade.

Boston Heart Diagnostics rolled out its test for the biomarker myeloperoxidase, which has been shown in studies to predict heart attack or stroke. The diagnostic is part of a range of tests the ...

The ROTEM system is a point‑of‑care device used to help detect, manage and monitor haemostasis associated with high blood loss. The device uses thromboelastometry, a viscoelastometric method, to test ...

The thrombin time assay is a versatile clinical assay used for screening fibrinogen related disorders and quantification of fibrin degradation products, as well as for detecting the presence of ...

Long COVID has become a significant public health concern, with coagulation and neurological complications arising during acute infection and persisting into the post-acute phase, contributing to ...